Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CWT-f-002 vs Systane in Dry Eye Disease
NCT05660681Completed
- Sponsor
- Calm Water Therapeutics
- Start
- Dec 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of CWT-F-002 in dry eye disease (DED) (2 arms), sponsored by Calm Water Therapeutics. Primary endpoint: Tear Film Break-up Time. Started Dec 2022; status: completed.
02
Drugs
CWT-F-002
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05660681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05660681.